The protein phosphatase (PP) inhibitors nodularin and microcystin-LR induced apoptosis with unprecedented rapidity, more than 50% of primary hepatocytes showing extensive surface budding and shrinkage of cytoplasm and nucleoplasm within 2 min. The apoptosis was retarded by the general caspase inhibitor Z-VAD.fmk. To circumvent the inefficient uptake of microcystin and nodularin into nonhepatocytes, toxins were microinjected into 293 cells, Swiss 3T3 fibroblasts, promyelocytic IPC-81 cells, and NRK cells. All cells started to undergo budding typical of apoptosis within 0.5 ± 3 min after injection. This was accompanied by cytoplasmic and nuclear shrinkage and externalization of phosphatidylserine. Overexpression of Bcl-2 did not delay apoptosis. Apoptosis induction was slower and Z-VAD.fmk independent in caspase-3 deficient MCF-7 cells. MCF-7 cells stably transfected with caspase-3 showed a more rapid and Z-VAD.fmk dependent apoptotic response to nodularin. Rapid apoptosis induction required inhibition of both PP1 and PP2A, and the apoptosis was preceded by increased phosphorylation of several proteins, including myosin light chain. The protein phosphorylation occurred even in the presence of apoptosis-blocking concentrations of Z-VAD.fmk, indicating that it occurred upstream of caspase activation. It is suggested that phosphatase-inhibiting toxins can induce caspase-3 dependent apoptosis in an ultrarapid manner by altering protein phosphorylation.
Introduction
Regulated (`programmed') cell death often occurs by a morphologically distinct series of events, termed apoptosis. 1, 2 Apoptotic cells are recognized by cell shrinkage, cell surface budding and chromatin hypercondensation. Specific cleavage of DNA, 2 RNA, 3 and`flipping' of phospholipids to the external face of the cell membrane 4, 5 are also commonly associated with apoptosis. Caspases are believed to be instrumental in the execution of regulated death. So far 14 members (caspase 1 ± 14) of the caspase family have been described. 6, 7 Some of these, like procaspase-8 and -2, can undergo autoactivation through multimerization, 8, 9 and in turn activate downstream procaspases 10 ± 12 and other proapoptotic proteins. 13 The Bcl-2 protein family contains members (Bcl-2, Bcl-x L ) that can protect against apoptosis. 16 Actions of Bcl-2 include the prevention of mitochondrial release of cytochrome c 15, 16 as well as of the apoptogenic action of cytoplasmic cytochrome c. 17 The mammary carcinoma cell line MCF-7 lacks both procaspase-3 and the ability to undergo apoptosis in response to injected cycochrome c 18, 19 and is a model to test for death which is independent of cytochrome c and caspase-3.
Altered protein phosphorylation (`dysphosphorylation') is known to be an important modulator of apoptosis induction and possibly apoptosis execution. This can occur either through action on protein kinases or protein phosphatases. 20 ± 22 It is intriguing that serine/threonine protein phosphatases 1 and 2A (PP1 and PP2A) are targeted by an array of chemically distinct microbial toxins. 23 We and others have shown that cell-permeant protein phosphatase inhibitors like okadaic acid 24, 25 are general inducers of apoptosis. 26 ± 29 We have postulated that the inhibitors act by short-cutting normal pathways of apoptosis induction. 23 A logical consequence of this would be that they could act faster than other apoptosis-inducers, if allowed immediate access to the intracellular compartment. This hypothesis was tested in the present study (1) by microinjecting a number of cell types with the water soluble phosphatase inhibitors 23 nodularin and microcystin, and (2) by exposing primary rat hepatocytes to high concentrations of these toxins in the medium. Hepatocytes are unique among mammalian cells in having an efficient transport system for microcystin and nodularin. 30 The question of whether protein phosphorylation was involved in toxin-induced death was addressed by temporal comparison of the cellular phosphoprotein pattern (studied by two-dimensional electrophoresis) with the development of apoptotic indices of cell death. It was also of interest to know whether inhibition of PP1, PP2A or both was required for rapid apoptosis induction, and whether the phosphorylation changes were upstream or downstream of caspase activation.
Results

Intracellularly delivered protein phosphatase inhibitors induce apoptosis ultrarapidly
Inhibitors of protein phosphatases 2A and 1 can induce apoptotic cell death in most, if not all, higher eukaryotic cells. 27, 29 Studies of the rate of apoptosis induction by phosphatase inhibitors have been hampered by the relatively slow cellular uptake of the commonly used membrane permeant inhibitors, tautomycin, okadaic acid and calyculin A 31 and by the lack of cellular uptake of the polar inhibitors microcystin-LR and nodularin in all cells except hepatocytes. 30 In introductory experiments cells were microinjected with all the mentioned inhibitors to test how rapidly cells could develop apoptosis following abrupt inhibition of their phosphatases. Tautomycin, okadaic acid and calyculin A all failed to produce apoptosis even when injected at concentrations up to 1 mM (data not shown). This could be due to rapid efflux or to preferential distribution to intracellular membranes of these hydrophobic compounds. Microinjection of either microcystin-LR (not shown) or nodularin produced extensive budding and rounding of Swiss 3T3 fibroblasts, human HEK 293 cells, and normal rat kidney (NRK) cells in a remarkably short time (Figure 1) . Semilogarithmic plots allowed a quantitative estimate of apoptosis progression as a function of time (Figures 1A ± C, 2A, 3A). The rectilinear nature of the plots showed that the entrance of cells into apoptosis obeyed first order kinetics. The apparent lag period before the onset of apoptosis was particularly short in HEK 293 cells (520 s) and fibroblasts (about 30 s). Such rapid apoptosis induction has not been reported previously.
The`flipping' of phosphatidylserine from the inner to the outer side of the plasma membrane has been found to be associated with apoptosis. 4, 5 To test for this phenomenon fibroblasts were injected with nodularin while bathed in a medium containing FITC-annexin V, which binds with high affinity to phosphatidylserine. When FITC-annexin V was added to already apoptotic cells, labeling was observed after 0.5 ± 1 min, suggesting that external phosphatidylserine should be observable within less than 1 min. Surface fluorescence could be seen in injected cells shortly after they had started budding ( Figure 1A, inset) . When the lag of staining is considered, it appeared that phosphatidylserine became externalized about simultaneously with cell budding. The staining was not due to penetration of FITC-annexin V into the cell with staining of intracellular phosphatidylserine, since the apoptotic cells excluded propidium iodide. Only cells that were deliberately injected under supraoptimal pressure to produce necrosis stained positively with both annexin V and propidium iodide ( Figure 1A) .
Condensation of chromatin was judged by fluorescence microscopy of cells stained with bisbenzimide to visualize DNA. In Swiss 3T3 fibroblasts, human HEK 293 cells, and normal rat kidney (NRK) cells chromatin condensation occurred a few minutes after injection of nodularin (Figure 1A , inset; data not shown).
The ultrarapid apoptosis induction by phosphatase inhibitors depends on caspase-3 and is not prevented by Bcl-2 overexpression
Since only a limited number of cells can be sampled within the first few minutes after microinjection, biochemical studies required a cell model where the toxin could act without microinjection. Ultrarapid induction of apoptosis could be achieved in hepatocytes without microinjection: nearly half of the hepatocytes showed apoptotic budding already after 2 min exposure to medium with 16 mM microcystin-LR (Figure 2A ) or 5 mM nodularin ( Figure 3A) . The morphological changes Figure  2B ). At this stage no buds had been cleaved off the cell, so loss of cell fragments could not account for the cytoplasmic shrinkage. The cell buds defined by light microscopy were found to contain organelles like mitochondria by electron microscopy ( Figure 2C ). This distinguished them from`toxic blebs', which have been described as a reversible phenomenon in cells exposed to toxic stress. 32 Hypercondensation of chromatin ( Figure 2C , lowest cell) occurred 80 ± 120 min after surface budding and shrinkage ( Figure 2D ).
In order to probe for caspase involvement the oligopeptide Z-VAD.fmk was tested for ability to block nodularininduced hepatocyte apoptosis. Z-VAD.fmk is a broad inhibitor of caspases, including caspase-3. 33 Hepatocytes preincubated with this peptide had strongly delayed apoptotic response to a maximally effective concentration (5 mM) of nodularin ( Figure 3A ). Other caspase inhibitors at similar concentrations, like BOC.fmk and Z-IETD.fmk, were much less efficient blockers than Z-VAD.fmk (not shown). This indicated that the Z-VAD part and not the released fmk moiety was responsible for the effect of Z-VAD.fmk. Additional evidence of caspase activation was provided by demonstrating procaspase-3 cleavage in hepatocytes exposed to nodularin. Immunoblotting showed increase of the 17 kDa cleavage peptide, which is known to be the active caspase-3 produced during proteolytic activation of Figure 3 The rapid nodularin-induced hepatocyte apoptosis depends on caspase activity and is associated with cleavage of procaspase-3. (A) Freshly prepared rat hepatocytes in suspension were exposed to 5 mM of the microcystin-like phosphatase inhibitor nodularin, which induced 50% apoptosis within 2 min (*). The nodularin induced apoptosis was moderately inhibited by preincubation with 50 mM of the general caspase inhibitor Z-VAD.fmk (*) and strongly inhibited by 200 mM Z-VAD.fmk (~). The insets in (A) show differential interference contrast micrographs of hepatocytes exposed to nodularin+Z-VAD.fmk. Error bars represent S.E.M. of 4 ± 7 separate experiments. (B) Samples of hepatocytes, exposed to nodularin as explained for (A), were centrifuged for 15 s and the pellet frozen in liquid nitrogen and processed for SDS electrophoresis and immuno-blotting to detect caspase-3 immuno-reactivity. The inset shows very rapid production of a 17 kDa cleavage product of procaspase-3, and the main part of (B) shows the time course of production of this 17 kDa cleavage product relative to the parent p32 procaspase procaspase-3. The increase was maximal already after 2 min of nodularin exposure ( Figure 3B ). This is an unusually rapid cleavage of procaspase-3, which is considered to be a`downstream' caspase, and has been shown to be activated at the earliest 10 min after Fasinduction. 18 A more rigorous test of caspase-3 involvement in nodularin-induced death was provided by experiments using the human breast carcinoma cell line MCF-7. The wild-type variant of these cells is devoid of caspase-3, 1819,34 and should be sub-sensitive to nodularin injection if caspase-3 was involved in phosphatase inhibitor induced apoptosis. MCF-7 wild-type cells (data not shown) or cells transfected with empty vector underwent apoptosis much more slowly than any other cells injected with nodularin, and apoptosis was not inhibited by Z-VAD.fmk ( Figure 4A ). MCF-7 cells overexpressing caspase-3 regained sensitivity to nodularin and to Z-VAD.fmk ( Figure 4B ). This suggested an important role of caspase-3 in the rapid death induced by nodularin. The slower, Z-VAD insensitive apoptosis induction in the caspase-3 deficient MCF-7 wild-type cells suggest the existence of an alternative, less efficient, apoptotic route which either relies on caspases resistant to Z-VAD.fmk or is completely caspase independent.
A number of experiments were conducted to probe if Bcl-2 overexpression could protect against phosphatase inhibitor induced death. First, promyelocytic IPC-81 cells with stable overexpression of Bcl-2 were tested. These cells were resistant to apoptosis induction by cAMP and up to 20 mM daunorubicin (data not shown), but showed no significant delay in apoptotic response to injected nodularin, as compared to the wild-type IPC-81 cells ( Figure 5 ). NRK cells and Swiss 3T3 fibroblasts were transiently transfected with bcl-2 expression vector, and tested for apoptosis development in response to microinjected nodularin and microinjected cytochrome c. No protection by Bcl-2 was observed even if the nodularin concentration in the injection solution was lowered to a level (50 mM) at which the rate of apoptosis induction was similar to that previously found after injection of cytochrome c, whose action was strongly inhibited in the Bcl-2 overexpressing cells. 35 In conclusion, nodularin-induced apoptosis appeared not to be readily blocked by Bcl-2.
Inhibitors of phosphatase 1 and 2A act synergistically to induce apoptosis
Microcystin and nodularin inhibit phosphatases 1 and 2A (PP1 and PP2A) with high potency. 23, 36 The polypeptides, inhibitor 1 and inhibitor 2, are considered completely specific for PP1, 37 and were tested in an attempt to know if selective inhibition of PP1 was sufficient to induce apoptosis. Neither peptide produced apoptosis when injected into primary rat hepatocytes in monolayer culture, while injection of an equimolar concentration (50 mM) of microcystin-LR gave significant apoptosis ( Figure 6A ). There is no known completely specific inhibitor of PP2A, but okadaic acid is about 200-fold more potent as inhibitor of PP2A than of PP1, 38 whereas tautomycin has preference for PP1. 39 A clear synergism between okadaic acid and tautomycin was noted for induction of hepatocyte apoptosis ( Figure 6B ), suggesting that both PP2A and PP1 were involved in this type of death.
It was of interest to probe whether PP1 and PP2A were required also for the slower caspase 3-independent death of MCF-7 wild-type cells. A previous study by Favre et al. 31 on intact MCF-7 cells showed that 1 mM okadaic acid produced selective and near complete inhibition of PP2A, whereas 10 mM tautomycin produce selective and near complete inhibition of PP1. When tested for apoptogenic activity against MCF-7 cells 1 mM okadaic acid had only a slight effect and 10 mM tautomycin had nearly no effect (not shown). This suggested that selective inhibition of either PP2A or PP1 was inefficient in producing apoptosis. When 1 mM okadaic acid was combined with 10 mM tautomycin a strong synergism was noted, suggesting involvement of Figure 4 Caspase-3 is required for ultrarapid induction of apoptosis in MCF-7 cells. Caspase-3 deficient parental MCF-7 cells were stably transfected with caspase-3 (*) or the pcDNA-3 vector alone (*) and injected with 500 mM nodularin. (A and B) show the time course of apoptosis development in the absence and presence, respectively, of ZVAD.fmk. In the mock-transfected wild-type cells the injection produced 50% apoptosis after about 15 min whether ZVAD,fmk was present or not. Similar results were obtained with wildtype cells not exposed to plasmid. The caspase-3 expressing cells had both shorter lag before onset of apoptosis and a higher rate constant for apoptosis development. In the presence of ZVAD.fmk both the lag period and the rate approached those seen in wild-type cells. Error bars represent S.E.M. of 3 ± 5 experiments both PP1 and PP2A also for apoptosis induction in wildtype MCF-7 cells.
Apoptosis is preceded by increased protein phosphorylation
The ability of nodularin and microcystin to produce physical evidence of apoptosis (cell shrinkage and cytoskeletal rearrangements) within 2 min (Figures 1 ± 3, 5 ) raised the question of whether phosphatase inhibition and resulting perturbation of protein phosphorylation could act fast enough to explain apoptosis development. To answer this question hepatocytes were preincubated with 32 P i to label the terminal phosphate of ATP, 40 and then exposed to nodularin. After 2 and 5 min of incubation the intracellular phosphorylation was stopped abruptly using trichloracetic acid, and the precipitated protein dissolved and separated by 2-dimensional gel electrophoresis. Autoradiograms of such gels showed that several proteins had increased phosphorylation intensity already after 2 min of incubation with nodularin ( Figure  7A ,B; spots a ± g). One group of phosphoproteins (labeled MLC in Figure 7A ) showing acid shift upon incubation with nodularin ( Figure 7B,C) was identified by Western-blot as myosin light chain ( Figure 7G ± J) . The intensity of the spots increased from 2 to 5 min of incubation and a few novel spots (h, i) were detected as well ( Figure 7C ). The finding of significant protein phosphorylation after only 2 min of incubation with nodularin supported the view that protein phosphorylation might be the prime mediator of nodularininduced apoptosis. An alternative explanation was that caspase activity had activated a protein kinase and thereby enhanced phosphorylation. This was tested in hepatocytes treated with Z-VAD.fmk under conditions delaying the onset of apoptosis to 5 min after nodularin treatment had started ( Figure 3A ). Significant hyperphosphorylation was observed after 2 min and considerably increased phosphorylation after 5 min even in cells pretreated with Z-VAD.fmk ( Figure 7D ± F) . Furthermore, a full acidic shift of myosin light chain was observed in such cells ( Figure 7J ). This argued that nodularininduced protein phosphorylation was not the result of Z-VADinhibitable caspase activity.
Discussion
Inhibition of phosphatases may be a particularly efficient way of harming cells, since a number of toxins from diverse microorganisms and of different chemical structure target the highly conserved protein phosphatases 2A and 1.
24,25,39,41 ± 43 The The concentration-dependence of okadaic acid as inducer of apoptosis in hepatocytes in suspension (*) and wild-type MCF-7 cells in monolayer culture (~). Okadaic acid preferentially inhibits protein phosphatase 2A, and became more potent as apoptosis inducer when combined (*,~) with concentrations of the protein phosphatase 1 preferring inhibitor tautomycin which by themselves failed to produce apoptosis. Hepatocytes were fixed after 20 min of incubation, and apoptosis determined by evaluating the cell surface morphology. Apoptosis in MCF-7 cells was determined after 2 h of incubation by evaluating nuclear morphology (hypercondensation of chromatin) in Hoechst 33342 stained cells apoptogenic effect of the hepatotoxic phosphatase inhibitors microcystin and nodularin seemed to be general, as it was produced by micro injection in all our tested cell lines. We and others have previously shown that cell-permeant protein phosphatase inhibitors like okadaic acid are general inducers of apoptosis and act independently of new protein synthesis. 27 ± 29 This implies that most, if not all, cells have the machinery required to undergo apoptosis in response to phosphatase inhibitors. The only other agent which is so generally apoptogenic as the phosphatase inhibitors appears to be staurosporine. 43 The primary apoptosis-mediating target of this broad kinase inhibitor is unknown, 45 but its action is blocked by Bcl-2 16 and involves mitochondrial leakage of cytochrome c. 46 The phosphatase inhibitor induced death was distinct from staurosporine induced death, since it was not counteracted by overexpression of Bcl-2.
The most striking finding of the present study was the rapidity with which phosphatase inhibitors could induce a complete apoptotic phenotype, including cell surface budding, cytoplasmic and nuclear shrinkage, externalization of phosphatidylserine, and procaspase cleavage. In most cases there is a lag of 30 min or more between application of a physiological apoptogenic stimulus and the first morphological signs of apoptosis. Examples hereof are the Fas/Apo-1/CD95-system 47 (and references therein), glucocorticoid-induced thymocyte apoptosis, 48 growth factor (e.g. IL-3) withdrawal, 49 and cAMP-induced apoptosis of the presently studied IPC-81 leukemia cells. 50 On the basis of the results presented, it seems reasonable to suggest that phosphatase inhibitors have evolved as rapidly lethal toxins by acquiring ability to short-cut normal apoptotic pathways, presumably acting close to the execution machinery. Short-cutting of death pathways acting through release of mitochondrial cytochrome c can be done by direct microinjection of cytochrome c into cells. 17, 35 Even injection of maximally efficient concentrations of cytochrome c acted five to ten times more slowly 17 than injected nodularin in inducing death of the presently studied cell lines. T-cell mediated cytotoxicity may be the best studied example of short-cutting of normal death pathways, and represents to our knowledge the most rapid apoptosis induction described before the present report. The target cell can undergo a mixture of necrotic and apoptotic changes as early as 3 ± 10 min after close contact with a killer cell. 51, 52 The death mechanism appears to be perforin-facilitated delivery of caspase-activating granzymes to the target cell. 53 On this basis it is not surprising that granzyme/perforin action is rapid, but all the more puzzling that phosphatase inhibitors acted even more rapidly.
Another striking finding of the present study was the much slower action of nodularin in cells devoid of caspase-3 as compared to the same cell type expressing caspase-3. Although caspase-3 cleavage was demonstrated very early in the nodularin treated hepatocytes it is possible that nodularin could induce reversible activation of procaspase-3 without cleavage, as well. It has recently been demonstrated that procaspase-3 can be reversibly activated by a peptide in the caspase-3 expressing MCF-7 cells used in the present study. 54 A major challenge will be to define the steps between nodularin addition to the cells and caspase-3 activation. The fact that a number of chemically distinct PP2A/PP1 targeting compounds induced apoptosis strongly suggests that protein phosphatase inhibition and not a nonspecific effect is the first step in nodularin-and microcystin-induced apoptosis. The present study suggests that inhibition of both phosphatases 1 and 2A was required to induce apoptosis. The overlapping substrate specificity of the two phosphatases 55, 56 may account for this dual requirement, since one protein phosphatase would substitute if the other one was inhibited. The concept that inhibition of dephosphorylation was instrumental in apoptosis induction was supported by the demonstration of significantly increased intracellular protein phosphorylation already after 2 min of nodularin treatment. This phosphorylation was apparently not the result of caspase dependent, apoptosis-associated activation of protein kinases, 57 since it was observed in cells in which apoptosis was repressed by the caspase inhibitor ZVAD.fmk. The link between protein hyperphosphorylation and caspase activation remains to be elucidated. 
Materials and Methods
Materials
Cells
Hepatocytes were isolated from male Wistar rats (120 ± 200 g) by in vitro collagenase perfusion and either cultured in monolayers on collagen as previously described 58 or kept in suspension. For the latter the hepatocytes (1.2610 6 cells/ml) were incubated at 378C in capped vials with gyratory shaking (175 cycles/min). The medium was pre-gassed (5% CO 2 /95% O 2 ) and consisted of 10 mM HEPES (pH 7.4), 120 mM NaCl, 5.3 mM KCl, 0.01 mM KH 2 PO 4 , 1.2 mM MgSO 4 , 1.0 mM CaCl 2 , 5 mM lactate, and 5 mM pyruvate.
Human embryo kidney HEK 293 cells and normal rat kidney NRK cells were grown in Dulbecco's modification of Eagle's minimal essential medium (DMEM) with 10% fetal calf serum, 50 U/ml of penicillin and 50 mg/ml streptomycin. Swiss 3T3 mouse embryo fibroblasts were grown in DMEM and RPMI 1640 (50/50 v/v), and supplemented with serum and antibiotics as described above.
Breast carcinoma cell line MCF-7 stably transfected with either caspase-3 or empty vector 56 were kindly provided by Dr. S Lord and N Henriques (Birmingham, UK). MCF-7 cell lines were cultured in RPMI supplemented with 2 mM glutamine and 10% fetal calf serum. Clones were selected for in media containing 500 mg/ml G418.
Rat promyelocytic IPC-81 leukemia cells were cultured in DMEM with 7% horse serum. IPC-81 cells with stable overexpression of Bcl-2 (IPC-81/bcl2) was a kind gift from Dr. Michel Lanotte (Institut d'He Â matologie, Paris, France). Selection for bcl-2 stable cells was done by culturing with puromycin at 0.5 mg/ml for 5 days every 30 days. No viable cells were found in cultures not transfected with bcl-2.
Cells were transfected with bcl-2 as previously described. 17 Some dishes were co-transfected with a lacZ-containing plasmid for estimation of transfection efficiency using a fluorescent b-galactosidase substrate. 59 The caspase inhibitor Z-VAD.fmk was added to the cell medium 20 ± 30 min before the cells were exposed to phosphatase inhibitors.
Microinjection
Microinjection was performed using an Eppendorf 5171 micromanipulator mounted on a Nikon Diaphot 300 inverted microscope. Microcapillaries (type BF100-10, 1.00/0.78) and puller (Model P-87) were from Sutter Instrument Co. (Novato, CA, USA). Optimal injections were obtained with capillary pipettes of which the tip diameter was less than 0.3 mm. Pipettes were loaded by retrograde filling. The injected volume was estimated as previously shown 60 to be close to 2% of the cellular volume, corresponding to 50-fold dilution of injected material. For each experimental parameter approximately 150 cells were injected. Phosphatase inhibitors were delivered in a buffer with 5% DMSO, but otherwise approaching the intracellular composition of electrolytes. 61 Inhibitor-1 was preincubated with 5 mM of the catalytic subunit of cAMP-dependent protein kinase and Mg 2+ /ATP prior to microinjection to ensure full activation of the inhibitor. 62 Additionally, cells injected with inhibitor-1 were sometimes exposed to 200 mM of cAMP analog (8-chlorothio-cAMP) to ensure continued activation of endogenous cAMP-dependent protein kinase. Control cells were injected with the relevant vehicles. In no case did injection of vehicle alone lead to significant apoptosis.
All injected cell types were cultured in 9.8 cm 2 dishes with grid patterns forming 4-mm 2 squares. HEK 293, NRK, Swiss 3T3, and MCF-7 cells (10 000 cells/cm 2 ) were injected 24 ± 48 h after seeding. Hepatocytes (30 000 cells/cm 2 ) were injected after 44 ± 56 h of culture. IPC-81 and IPC-81-bcl-2 cells to be injected were seeded at 30 000 cells/cm 2 in dishes precoated with fibronectin (1 mg/cm 2 ), and treated with 100 nM of the phorbol ester TPA to further improve cell attachment (for details see Vintermyr et al. 63 )
Scoring of apoptotic morphology
For routine assessment of apoptosis, the cell morphology was evaluated by inverted phase microscopy using phase-and Hoffman modulated-optics. Apoptotic cells were easily discriminated from nonapoptotic (both normal and necrotic) cells by the appearance of multiple surface buds. For evaluation of the chromatin condensation, cells fixed in 0.1 M Na-cacodylate buffer (pH 7.4) with 1.5% glutaraldehyde were stained with 1 mg/ml of the DNA-specific dye Hoechst 33342 (bisbenzimide). When surface features were to be illustrated in bisbenzimide-stained cells, they were double-exposed using both fluorescence and differential interference contrast microscopy. The progress of apoptosis in a cell population was evaluated quantitatively by plotting semilogarithmically the fraction of cells remaining non-apoptotic against time. In most cases this plot became rectilinear after a lag period and its slope gave the rate constant for the transition from normal to apoptotic phenotype. For transmission electron microscopy cell aliquots were fixed in 10-fold excess of 1.5% glutaraldehyde buffered with 0.1 M Nacacodylate (pH 7.4) and processed as described previously. 27 Estimation of the nuclear and cell volume was determined on semithin toluidine blue-stained sections using a semiautomatic image analyzer and a primary magnification of 6306. Phosphatidylserine was visualized by incubating cells with FITC-conjugated Annexin IV (according to 64 ) Since annexin V can bind to phosphatidylserine on the internal side of the plasma membrane if the plasma membrane is not intact the cells were counterstained with 5 mg/ml propidium iodide to detect membrane leaks. The cells were scored using a filter set for FITC-staining with a long-pass filter for the simultaneous detection of propidium iodide. Only propidium iodine-negative annexin V-staining cells were considered certain to have externalized phosphatidylserine.
Labeling of cellular phosphoproteins and 2-dimensional gel electrophoresis
Suspension cultures of hepatocytes were preincubated with 32 P i (1000 mCi/ml) for 35 min before the addition of nodularin. The incubations were terminated by adding a tenfold excess of ice-cold 8% aqueous trichloroacetic acid. Samples were spun (15 0006g for 15 min) and washed in 5% aqueous trichloroacetic acid. Cell pellets were lyzed in 100 ml of a solution containing 9.8 M urea, 100 mM DTE (1,4-dithioerythritol), 1.5% v/v Pharmalyte pH 3.5 ± 10, 0.5% v/v Pharmalyte pH 5-6, 4% w/v CHAPS (3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate) and 0.2% w/v SDS. The 2-dimensional sample separation was as described in, 65 using a linear immobilized pH 4.0 ± 7.0 gradient for the first dimension and 13.75% SDS ± PAGE for the second dimension.
Western blot analysis
For immunodetection (Western blot) of myosin light chain, proteins were transferred from 2-dimensional gels by electroblotting (70 h at 15 V, 48C) onto nitrocellulose membranes. Blots were incubated with anti-myosin light chain antibody followed by horseradish peroxidaseconjugated sheep anti-mouse antibody. The blots were developed using ECL (Pharmacia, Uppsala, Sweden). For immunodetection of caspase-3, hepatocytes (10 6 ) treated with apoptogen were rapidly centrifuged, and the pellet frozen in liquid nitrogen. The pellet was resuspended in Laemmli buffer supplemented with a cocktail of protease inhibitors (1 mM PMSF, 1 mM 1,10-phenantroline, 20 mg/ml leupeptin, 5 mg/ml pepstatin and 20 mg/ml calpain inhibitor I). After boiling for 4 min, the polypeptides were resolved at 130 V on 12% SDS polyacrylamide gels. The gels were transblotted onto nitrocellulose membranes (0.2 mm) for 2 h at 100 V. The membranes were blocked overnight in a buffer (50 mM Tris, pH 7.5, 500 mM NaCl) containing 1% bovine serum albumin and 5% nonfat milk powder. They were then probed with primary antibodies against p17 in blocking solution without milk, followed by 1 h with secondary IgG (1 : 10 000 in an identical solution), and then visualized by ECL according to the manufacturer. The ratio between the cleavage product (p17) and procaspase-3 (p32) was determined by computerassisted densitometric evaluation.
